CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 4 Derivatives Options or other derivatives
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Material agreement · Other events
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 10-K Report Annual Report
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Chief Commercial Officer acquired 30,000 shares (option exercise)
- 4 Option exercise Chief Financial Officer acquired 30,000 shares (option exercise)
- 8-K Event Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Results of operations
Page 23 of 44 · 872 filings